FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells.

FGF-2 is involved in cell survival, proliferation, apoptosis, and angiogenesis in a wide variety of cells. FRGRs, PI3K and MAP kinases are well known mediators of FGF signaling. Despite its known roles during many developmental processes, including osteogenesis, there are few known targets of FGF-2. In the present study, we identified Bcl2-A1 and Bcl-xL as two prominent targets involved in promoting cell survival. Pretreatment of ATDC5 cells with FGF-2 increased cell survival, while siRNAs specific for Bcl2-A1 and Bcl-xL compromised the anti- apoptotic effect of FGF-2, sensitized the cells to apoptosis triggered by TNF-α. Chemical inhibition of FGFR, NFkB, and PI3K activity by PD173074, pyrrolidine dithiocarbamate, and LY294002 respectively abrogated the FGF-2-mediated induction of Bcl2-A1 and Bcl-xL expression. Taken together, our data demonstrate that a subset of Bcl2 family proteins are the targets of FGF-2 signaling that promotes the survival of ATDC5 cells.

[1]  G. Cohen,et al.  The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein. , 2011, Biochemical and biophysical research communications.

[2]  T. He,et al.  Lysophosphatidic Acid Acyltransferase β (LPAATβ) Promotes the Tumor Growth of Human Osteosarcoma , 2010, PloS one.

[3]  Lin Feng,et al.  FKBP38 Protects Bcl-2 from Caspase-dependent Degradation* , 2010, The Journal of Biological Chemistry.

[4]  F. Muchemwa,et al.  Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways , 2009, The British journal of dermatology.

[5]  Joong-Kook Choi,et al.  Enhanced cytotoxicity of 5-FU by bFGF through up-regulation of uridine phosphorylase 1 , 2009, Molecules and cells.

[6]  J. Saklatvala,et al.  Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. , 2009, Arthritis and rheumatism.

[7]  L. Thompson,et al.  STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes , 2008, Journal of Cell Science.

[8]  R. Moots,et al.  The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. , 2008, Blood.

[9]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[10]  D. Andrews,et al.  Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line , 2006, BMC Cancer.

[11]  B. Ng,et al.  Fibroblast Growth Factor 2-Mediated Translational Control of IAPs Blocks Mitochondrial Release of Smac/DIABLO and Apoptosis in Small Cell Lung Cancer Cells , 2003, Molecular and Cellular Biology.

[12]  Rivka L. Glaser,et al.  The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutations in sperm. , 2003, American journal of human genetics.

[13]  G. McVean,et al.  Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line , 2003, Science.

[14]  K. Nakayama,et al.  Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis , 2003, Nature Cell Biology.

[15]  D. Ornitz,et al.  Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. , 2001, Development.

[16]  A. Karsan,et al.  A1 Functions at the Mitochondria to Delay Endothelial Apoptosis in Response to Tumor Necrosis Factor* , 2000, The Journal of Biological Chemistry.

[17]  E. Jabs,et al.  The pleiotropic effects of fibroblast growth factor receptors in mammalian development. , 2000, Cell structure and function.

[18]  Marty W. Mayo,et al.  NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis , 1999, Molecular and Cellular Biology.

[19]  D. Levy,et al.  FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. , 1999, Genes & development.

[20]  D. Baltimore,et al.  Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Karsan,et al.  Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1* , 1996, The Journal of Biological Chemistry.

[22]  V. Papaioannou,et al.  Requirement of FGF-4 for postimplantation mouse development , 1995, Science.

[23]  M. Berger,et al.  Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.

[24]  T. Smith,et al.  J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. , 1991, Biochemistry.